In: Finance
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.45 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.6 million packages a year. Cash costs of production in the first year are expected to be $4.20 per package in real terms for the headache-only brand. Production costs are expected to be $4.75 in real terms for the headache and arthritis pill. All prices and costs are expected to rise at the general inflation rate of 3 percent.
Either product requires further investment. The headache-only pill could be produced using equipment costing $20 million. That equipment would last three years and have no resale value. The machinery required to produce the broader remedy would cost $29 million and last three years. The firm expects that equipment to have a $1,000,000 resale value (in real terms) at the end of Year 3. The firm uses straight-line depreciation and has a tax rate of 22 percent. The appropriate real discount rate is 7 percent.
a. |
Calculate the NPV for headache pain reliever only. |
b. | Calculate the NPV for headache and arthritis pain reliever |
Resale value and discount rate are given in real terms. so, project cash flows should also be in real terms.
NPV = Present value of cash inflows - initial investment
a. NPV for headache pain reliever only
Years | 0 | 1 | 2 | 3 | Total | |
Cost of equipment | -$20,000,000 | 0 | 0 | 0 | -$20,000,000 | |
Sales quantity | 0 | 3000000 | 3000000 | 3000000 | ||
Sales price/unit | 0 | $8.45 | $8.45 | $8.45 | ||
Production cost/unit | 0 | $4.20 | $4.20 | $4.20 | ||
Sales | $0 | $25,350,000 | $25,350,000 | $25,350,000 | $76,050,000 | |
Less: | Production cost | $0 | $12,600,000 | $12,600,000 | $12,600,000 | $37,800,000 |
Less: | Depreciation | $0 | $6,666,667 | $6,666,667 | $6,666,667 | $20,000,000 |
Pre-tax cash flow | $0 | $6,083,333 | $6,083,333 | $6,083,333 | $18,250,000 | |
Less: | Taxes @22% | $0 | $1,338,333 | $1,338,333 | $1,338,333 | $4,015,000 |
After-tax cash flow | $0 | $4,745,000 | $4,745,000 | $4,745,000 | $14,235,000 | |
Add back: | Depreciation | $0 | $6,666,667 | $6,666,667 | $6,666,667 | $20,000,000 |
Add: | Sale of equipment | $0 | $0 | $0 | $0 | $0 |
Less: | Tax on equip. sale | $0 | $0 | $0 | $0 | $0 |
Operating cash flow | -$20,000,000 | $11,411,667 | $11,411,667 | $11,411,667 | $14,235,000 | |
NPV | $9,947,820 |
Formulas
b. NPV for headache and arthritis pain reliever
Tax on resale value of equipment = (sale value - book value)*tax rate
Book value = cost of equipment - total depreciation
depreciation = (cost of equipment - resale value)/life of equipment
Years | 0 | 1 | 2 | 3 | Total | |
Cost of equipment | -$29,000,000 | 0 | 0 | 0 | -$29,000,000 | |
Sales quantity | 0 | 4600000 | 4600000 | 4600000 | ||
Sales price/unit | 0 | $8.45 | $8.45 | $8.45 | ||
Production cost/unit | 0 | $4.75 | $4.75 | $4.75 | ||
Sales | $0 | $38,870,000 | $38,870,000 | $38,870,000 | $116,610,000 | |
Less: | Production cost | $0 | $21,850,000 | $21,850,000 | $21,850,000 | $65,550,000 |
Less: | Depreciation | $0 | $9,333,333 | $9,333,333 | $9,333,333 | $28,000,000 |
Pre-tax cash flow | $0 | $7,686,667 | $7,686,667 | $7,686,667 | $23,060,000 | |
Less: | Taxes @22% | $0 | $1,691,067 | $1,691,067 | $1,691,067 | $5,073,200 |
After-tax cash flow | $0 | $5,995,600 | $5,995,600 | $5,995,600 | $17,986,800 | |
Add back: | Depreciation | $0 | $9,333,333 | $9,333,333 | $9,333,333 | $28,000,000 |
Add: | Sale of equipment | $0 | $0 | $0 | $1,000,000 | $1,000,000 |
Less: | Tax on equip. sale | $0 | $0 | $0 | $0 | $0 |
Operating cash flow | -$29,000,000 | $15,328,933 | $15,328,933 | $16,328,933 | $17,986,800 | |
NPV | $12,044,264 |
Formulas